| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | +12.3% |
| Cost of Revenue | $192K | — | -2.0% |
| Gross Profit | $1.2M | — | +14.9% |
| R&D Expense | $5.5M | — | +197.6% |
| SG&A Expense | $6.3M | — | +314.8% |
| Operating Income | -$11.8M | — | -192.8% |
| Pre-tax Income | -$10.8M | — | -225.0% |
| Net Income | -$10.8M | — | -225.0% |
| EPS (Basic) | -$3.10 | — | -110.9% |
| EPS (Diluted) | -$3.10 | — | -110.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | +961.9% | +353.8% |
| Accounts Receivable | $216K | -19.7% | — |
| Current Assets | $3.8M | +411.8% | — |
| Total Assets | $4.5M | +210.5% | — |
| Current Liabilities | $16.4M | +7686.6% | — |
| Total Liabilities | $16.6M | -36.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | -104.1% |
| Capital Expenditures | $5K | — | -58.3% |
| Investing Cash Flow | -$5K | — | +58.3% |
| Financing Cash Flow | $5.6M | — | +430.6% |
| Free Cash Flow | -$2.6M | — | -102.6% |
| — |
| Stockholders' Equity | -$12.0M | -5632.6% | +62.8% |